PRA buys out Takeda JV in Japan
PRA Health Sciences has bought out its joint venture with Takeda, establishing a new subsidiary based in Japan – a rapidly growing market, says EVP.
Archives for July 30, 2019
Phesi’s SaaS predicts ‘what if’ and eases site selection costs, delays
Phesi launches an AI-powered SaaS solution to mitigate potential costly delays through a search and select investigator function to determine trial sites for clinical studies.
Iqvia sees ‘a lot of runway ahead’ despite growth in Q2
Iqvia is looking to the future and opportunities in AI, after reporting $2.74bn in revenue for Q2 FY19.
Immodulon adopts AI tool to accelerate pancreatic cancer clinical trial
Immodulon to utilize biomarkers identified by Biodesix’ machine learning platform, aiming to accelerate the clinical development of its pancreatic treatment.
Litmus Health releases next-gen clinical research platform
Litmus Health today released a new version of its end-to-end real-world data platform for clinical research – as the industry increasingly adopts wearable technology to monitor patients in their homes, says CMO.
Demand for Gardasil leads to $650m investment in Merck’s operations
Merck to invest in its North Carolina facilities as it expands production capacity to meet demand for its HPV vaccine Gardasil, and grow its packaging operations
Mapi to establish $13m manufacturing plant for Copaxone generic
Mapi to turn a facility previously owned by J&J into a manufacturing plant for the production of GA Depot, a long-acting generic of Teva’s Copaxone.